Mutation type*1 |
Mutation position |
Length of affected nucleotides |
Nucleotide sequence after mutation |
Mutation name |
Case # |
Consequence |
Organ |
Tumor |
Subtype/note |
Origin |
Zygosity |
Reference |
LD |
82 |
321 |
|
82del321 |
1 |
321-bp del at ntd 82-402 -> del at codon 28-134 |
Stomach |
gastric carcinoma |
Signet ring cell carcinoma |
HSC-39, HSC40A (cell line) |
Homozygous |
Oyama, T. et al Cancer Res 54, 6282 (1994) |
M |
98 |
1 |
A |
S33Y |
1 |
TCT-TAT at ntd 98 -> Ser-Tyr at codon 33 |
Colon |
colorectal carcinoma |
ND*2 |
SW48 (cell line) |
Heterozygous |
Ilyas, M. et al Proc Natl Acad Sci U S A 94, 10330 (1997) |
D |
133 |
3 |
|
133delTCT |
1 |
3-bp del of TCT at ntd 133-135 -> del of Ser at codon 45 |
Colon |
colorectal carcinoma |
ND |
HCT116 (cell line) |
Heterozygous |
Ilyas, M. et al Proc Natl Acad Sci U S A 94, 10330 (1997) |
M |
547 |
1 |
T |
A183S |
1 |
GCT-TCT at ntd 547 -> Ala-Ser at codon 183 |
Colon |
colorectal carcinoma |
ND |
HCA46 (cell line) |
Heterozygous |
Ilyas, M. et al Proc Natl Acad Sci U S A 94, 10330 (1997) |
M |
734 |
1 |
C |
G245A |
1 |
GGT-GCT at ntd 734 -> Gly-Ala at codon 245 |
Colon |
colorectal carcinoma |
ND |
Caco2 (cell line) |
Heterozygous |
Ilyas, M. et al Proc Natl Acad Sci U S A 94, 10330 (1997) |
M |
860 |
1 |
G |
N287S |
1 |
AAC-AGC at ntd 860 -> Asn-Ser at codon 287 |
Colon |
colorectal carcinoma |
ND |
Colo201/205 (cell line) |
Homozygous |
Ilyas, M. et al Proc Natl Acad Sci U S A 94, 10330 (1997) |
M |
98 |
1 |
T |
S33F |
1 |
TCT-TTT at ntd 98 -> Ser-Phe at codon 33 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
109 |
1 |
G |
S37A |
1 |
TCT-GCT at ntd 109 -> Ser-Ala at codon 37 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
110 |
1 |
G |
S37C |
1 |
TCT-TGT at ntd 110 -> Ser-Cys at codon 37 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
121 |
1 |
G |
T41A |
1 |
ACC-GCC at ntd 121-> Thr-Ala at codon 41 |
Uterus |
adenosquamous carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
121 |
1 |
G |
T41A |
1 |
ACC-GCC at ntd 121-> Thr-Ala at codon 41 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
122 |
1 |
T |
T41I |
2 |
ACC-ATC at ntd 122 -> Thr-Ile at codon 41 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
134 |
1 |
T |
S45F |
2 |
TCT-TTT at ntd 134 -> Ser-Phe at codon 45 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
134 |
1 |
G |
S45C |
1 |
TCT-TGT at ntd 134 -> Ser-Cys at codon 45 |
Uterus |
endometriod carcinoma |
ND |
ND |
ND |
Fukuchi, T et al Cancer Res 58, 3526 (1998) |
M |
110 |
1 |
G |
S37C |
1 |
TCT-TGT at ntd 110 -> Ser-Cys at codon 37 |
Ovary |
endometriod carcinoma |
ND |
ND |
ND |
Palacios, J. et al Cancer Res 58, 1344 (1998) |
M |
110 |
1 |
T |
S37F |
1 |
TCT-TTT at ntd 110 -> Ser-Phe at codon 37 |
Ovary |
endometriod carcinoma |
ND |
ND |
ND |
Palacios, J. et al Cancer Res 58, 1344 (1998) |
M |
121 |
1 |
G |
T41A |
1 |
ACC-GCC at ntd 121-> Thr-Ala at codon 41 |
Ovary |
endometriod carcinoma |
ND |
ND |
ND |
Palacios, J. et al Cancer Res 58, 1344 (1998) |
M |
94 |
1 |
T |
D32Y |
1 |
GAC-TAC at ntd 94 -> Asp-Tyr at codon 32 |
Prostate |
ND |
ND |
ND |
ND |
Voeller, H. J. et al Cancer Res 58, 2520 (1998) |
M |
98 |
1 |
T |
S33F |
2 |
TCT-TTT at ntd 98 -> Ser-Phe at codon 33 |
Prostate |
ND |
ND |
ND |
ND |
Voeller, H. J. et al Cancer Res 58, 2520 (1998) |
M |
121 |
1 |
G |
T41A |
1 |
ACC-GCC at ntd 121-> Thr-Ala at codon 41 |
Prostate |
ND |
ND |
ND |
ND |
Voeller, H. J. et al Cancer Res 58, 2520 (1998) |
D |
133 |
3 |
|
133delTCT |
1 |
3-bp del of TCT at ntd 133-135 -> del of Ser at codon 45 |
Prostate |
ND |
ND |
ND |
ND |
Voeller, H. J. et al Cancer Res 58, 2520 (1998) |
LD |
13+58 |
677 |
|
IVS2+58del677 |
1 |
deletion of exon 3 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Homozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
13+61 |
760 |
|
IVS2+61del760 |
1 |
deletion of exon 3 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Heterozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
13+63 |
656 |
|
IVS2+63del656 |
1 |
deletion of exon 3 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Heterozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
13+166 |
653 |
|
IVS2+166del653 |
1 |
deletion of exon 3 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Heterozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
13+282 |
407 |
|
IVS2+282del407 |
1 |
deletion of exon 3 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Heterozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
13+379 |
333 |
|
IVS2+379del333 |
1 |
deletion of exon 3 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Heterozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
68 |
234 |
|
68del234 |
1 |
234-bp del at ntd 68 - IVS3-128 -> del at codon 23-80 |
Colon |
primary colorectal carcinoma |
w/o APC mutation |
ND |
Heterozygous |
Iwao, K. et al Cancer Res 58, 1021 (1998) |
LD |
14-45 |
195 |
|
IVS2-45del195 |
1 |
195-bp del at IVS2-45 - ntd 162 -> del at codon 5-54 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
94 |
1 |
A |
D32N |
3 |
GAC-AAC at ntd 94 -> Asp-Asn at codon 32 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
94 |
1 |
T |
D32Y |
2 |
GAC-TAC at ntd 94 -> Asp-Tyr at codon 32 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
97 |
1 |
C |
S33P |
1 |
TCT-CCT at ntd 97 -> Ser-Pro at codon 33 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
101 |
1 |
T |
G34V |
1 |
GGA-GTA at ntd 101-> Gly-Val at codon 34 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
ID |
107 |
52 |
T |
107indel52->T |
1 |
52-bp del at ntd 107-158 and ins T -> del at codon 36-53 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
121 |
1 |
G |
T41A |
1 |
ACC-GCC at ntd 121-> Thr-Ala at codon 41 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
133 |
1 |
C |
S45P |
2 |
TCT-CCT at ntd 133 -> Ser-Pro at codon 45 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
134 |
1 |
T |
S45F |
2 |
TCT-TTT at ntd 134 -> Ser-Phe at codon 45 |
Liver |
primary hepatocellular carcinoma |
ND |
ND |
ND |
Miyoshi, Y. et al Cancer Res 58, 2524 (1998) |
M |
110 |
1 |
G |
S37C |
1 |
TCT-TGT at ntd 110 -> Ser-Cys at codon 37 |
ND |
Sporadic medulloblastoma |
Turcot's syndrome |
ND |
ND |
Zurawel, R. et al Cancer Res 58, 896 (1998) |
M |
110 |
1 |
G |
S37C |
2 |
TCT-TGT at ntd 110 -> Ser-Cys at codon 37 |
ND |
Sporadic medulloblastoma |
Turcot's syndrome |
ND |
ND |
Zurawel, R. et al Cancer Res 58, 896 (1998) |
M |
94 |
1 |
A |
D32N |
1 |
GAT-AAT at ntd 94 -> Asp-Asn at codon 32 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
95 |
1 |
G |
D32G |
1 |
GAT-GGT at ntd 95 -> Asp-Gly at codon 32 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
94 |
1 |
A |
D32N |
1 |
GAT-AAT at ntd 94 -> Asp-Asn at codon 32 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
98 |
1 |
T |
S33F |
1 |
TCT-TTT at ntd 98 -> Ser-Phe at codon 33 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
101 |
1 |
A |
G34E |
1 |
GGA-GAA at ntd 101-> Gly-Glu at codon 34 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
101 |
1 |
A |
G34E |
1 |
GGA-GAA at ntd 101-> Gly-Glu at codon 34 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
101 |
1 |
A |
G34E |
1 |
GGA-GAA at ntd 101-> Gly-Glu at codon 34 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
122 |
1 |
T |
T41I |
1 |
ACC-ATC at ntd 122 -> Thr-Ile at codon 41 |
Colon (Rat) |
Azoxymethane-induced colon tumor |
ND |
ND |
ND |
Takahashi, M. et al Cancer Res 58, 42 (1998) |
M |
94 |
1 |
A |
D32N |
3 |
GAT-AAT at ntd 94 -> Asp-Asn at codon 32 |
Colon (Rat) |
Heterocyclic amines-induced colon tumor |
ND |
ND |
ND |
Dashwood, R. H. et al Cancer Res 58, 1127 (1998) |
M |
101 |
1 |
T |
G34V |
|
GGA-GTA at ntd 101-> Gly-Val at codon 34 |
Colon (Rat) |
Heterocyclic amines-induced colon tumor |
ND |
ND |
ND |
Dashwood, R. H. et al Cancer Res 58, 1127 (1998) |
M |
101 |
1 |
A |
G34E |
|
GGA-GAA at ntd 101-> Gly-Glu at codon 34 |
Colon (Rat) |
Heterocyclic amines-induced colon tumor |
ND |
ND |
ND |
Dashwood, R. H. et al Cancer Res 58, 1127 (1998) |
M |
104 |
1 |
G |
I35S |
1 |
ATC-AGC at ntd 104 -> Ile-Ser at codon 35 |
Colon (Rat) |
Heterocyclic amines-induced colon tumor |
ND |
ND |
ND |
Dashwood, R. H. et al Cancer Res 58, 1127 (1998) |
M |
110 |
1 |
G |
S37C |
2 |
TCT-TGT at ntd 110 -> Ser-Cys at codon 37 |
Colon (Rat) |
Heterocyclic amines-induced colon tumor |
ND |
ND |
ND |
Dashwood, R. H. et al Cancer Res 58, 1127 (1998) |